Thermo Fisher Q3 revenue, adj profit beat estimates after new product launches

Thermo Fisher Scientific

Yesterday 11:10

Overview
Lab equipment supplier's Q3 revenue rose 9%, beating analyst expectations
Adjusted EPS for Q3 grew 15%, beating analyst expectations
Company cites growth strategy, new products, and execution as drivers of results

Outlook
Thermo Fisher will provide updated 2026 financial guidance during its earnings call

Result Drivers
NEW PRODUCTS - Co said Q3 results were driven by launches of new products including Orbitrap Isora mass spectrometer, EMPAD G2 electron detector, EliA CTD 13 Screen autoimmune test, and Ion 560 sequencing chip
COMMERCIAL ENGINE - Co said it strengthened its commercial engine and deepened customer partnerships, including new initiatives with Mayo Clinic and opening an AI-Automation Innovation Center in South Korea
EXECUTION - Co attributed results to execution enabled by its PPI Business System

Company press release: ID:nBw15K2sXa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$12.14 bln
$11.95 bln (21 Analysts)
Q3 Adjusted EPS
Beat
$6.68
$6.40 (22 Analysts)
Q3 EPS
 
$4.64
 
Q3 Adjusted Net Income
Beat
$2.48 bln
$2.38 bln (15 Analysts)

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 27 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Thermo Fisher Scientific Inc. is $705.00, about 2.6% above its October 20 closing price of $687.37
The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 19 three months ago

Reuters Recommended Reads
Oct 20 - 3M tops Q3 adjusted EPS estimates, raises guidance
Oct 20 - Intuitive Surgical Q3 results top estimates on higher da Vinci system placements

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)